Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.32
DOW's Cash to Debt is ranked lower than
65% of the 1000 Companies
in the Global Chemicals industry.

( Industry Median: 0.60 vs. DOW: 0.32 )
Ranked among companies with meaningful Cash to Debt only.
DOW' s 10-Year Cash to Debt Range
Min: 0.02  Med: 0.19 Max: 0.69
Current: 0.32
0.02
0.69
Equity to Asset 0.34
DOW's Equity to Asset is ranked lower than
79% of the 858 Companies
in the Global Chemicals industry.

( Industry Median: 0.53 vs. DOW: 0.34 )
Ranked among companies with meaningful Equity to Asset only.
DOW' s 10-Year Equity to Asset Range
Min: 0.19  Med: 0.32 Max: 0.4
Current: 0.34
0.19
0.4
Interest Coverage 5.56
DOW's Interest Coverage is ranked lower than
82% of the 561 Companies
in the Global Chemicals industry.

( Industry Median: 47.01 vs. DOW: 5.56 )
Ranked among companies with meaningful Interest Coverage only.
DOW' s 10-Year Interest Coverage Range
Min: 0.31  Med: 4.23 Max: 8.82
Current: 5.56
0.31
8.82
F-Score: 5
Z-Score: 2.54
M-Score: -3.01
WACC vs ROIC
6.04%
10.42%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 9.99
DOW's Operating margin (%) is ranked higher than
74% of the 986 Companies
in the Global Chemicals industry.

( Industry Median: 5.20 vs. DOW: 9.99 )
Ranked among companies with meaningful Operating margin (%) only.
DOW' s 10-Year Operating margin (%) Range
Min: -1.4  Med: 7.95 Max: 18.96
Current: 9.99
-1.4
18.96
Net-margin (%) 8.24
DOW's Net-margin (%) is ranked higher than
72% of the 987 Companies
in the Global Chemicals industry.

( Industry Median: 3.67 vs. DOW: 8.24 )
Ranked among companies with meaningful Net-margin (%) only.
DOW' s 10-Year Net-margin (%) Range
Min: -1.38  Med: 6.53 Max: 10.25
Current: 8.24
-1.38
10.25
ROE (%) 17.03
DOW's ROE (%) is ranked higher than
80% of the 974 Companies
in the Global Chemicals industry.

( Industry Median: 6.96 vs. DOW: 17.03 )
Ranked among companies with meaningful ROE (%) only.
DOW' s 10-Year ROE (%) Range
Min: -3.84  Med: 15.84 Max: 32.72
Current: 17.03
-3.84
32.72
ROA (%) 6.47
DOW's ROA (%) is ranked higher than
70% of the 1009 Companies
in the Global Chemicals industry.

( Industry Median: 3.53 vs. DOW: 6.47 )
Ranked among companies with meaningful ROA (%) only.
DOW' s 10-Year ROA (%) Range
Min: -1.08  Med: 5.40 Max: 9.83
Current: 6.47
-1.08
9.83
ROC (Joel Greenblatt) (%) 27.15
DOW's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 1003 Companies
in the Global Chemicals industry.

( Industry Median: 9.79 vs. DOW: 27.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DOW' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.7  Med: 22.24 Max: 64.77
Current: 27.15
0.7
64.77
Revenue Growth (3Y)(%) -1.80
DOW's Revenue Growth (3Y)(%) is ranked lower than
72% of the 787 Companies
in the Global Chemicals industry.

( Industry Median: 3.90 vs. DOW: -1.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
DOW' s 10-Year Revenue Growth (3Y)(%) Range
Min: -5.5  Med: 3.60 Max: 16.1
Current: -1.8
-5.5
16.1
EBITDA Growth (3Y)(%) 3.90
DOW's EBITDA Growth (3Y)(%) is ranked higher than
54% of the 697 Companies
in the Global Chemicals industry.

( Industry Median: 2.10 vs. DOW: 3.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
DOW' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -27.9  Med: 1.00 Max: 63
Current: 3.9
-27.9
63
EPS Growth (3Y)(%) 11.80
DOW's EPS Growth (3Y)(%) is ranked higher than
65% of the 629 Companies
in the Global Chemicals industry.

( Industry Median: 3.60 vs. DOW: 11.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
DOW' s 10-Year EPS Growth (3Y)(%) Range
Min: -61.4  Med: -4.60 Max: 52
Current: 11.8
-61.4
52
» DOW's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

DOW Guru Trades in Q3 2014

Larry Robbins 2,417,900 sh (New)
Ruane Cunniff 41,000 sh (New)
First Eagle Investment 100,000 sh (New)
John Burbank 1,135,490 sh (+4537.87%)
Jim Simons 1,013,300 sh (+394.29%)
Steven Cohen 609,800 sh (+272.51%)
George Soros 2,918,714 sh (+253.44%)
Paul Tudor Jones 83,261 sh (+171.93%)
Manning & Napier Advisors, Inc 137,617 sh (+14.28%)
Signature Select Canadian Fund 158,700 sh (+3.52%)
Daniel Loeb 22,000,000 sh (unchged)
Daniel Loeb 7,250,000 sh (unchged)
John Burbank 100,000 sh (unchged)
Jeff Auxier 98,722 sh (unchged)
Pioneer Investments 1,470,500 sh (unchged)
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
David Dreman Sold Out
PRIMECAP Management 1,654,255 sh (-0.39%)
Joel Greenblatt 66,905 sh (-4.16%)
Dodge & Cox 5,763,629 sh (-45.34%)
» More
Q4 2014

DOW Guru Trades in Q4 2014

John Hussman 3,500 sh (New)
Ray Dalio 31,188 sh (New)
Joel Greenblatt 221,271 sh (+230.72%)
George Soros 5,183,739 sh (+77.60%)
Manning & Napier Advisors, Inc 208,586 sh (+51.57%)
Larry Robbins 3,057,000 sh (+26.43%)
First Eagle Investment 100,000 sh (unchged)
Jeff Auxier 98,722 sh (unchged)
Daniel Loeb 22,000,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
John Burbank Sold Out
Ruane Cunniff Sold Out
Pioneer Investments 1,467,548 sh (-0.20%)
PRIMECAP Management 1,625,150 sh (-1.76%)
Paul Tudor Jones 77,788 sh (-6.57%)
Dodge & Cox 780,731 sh (-86.45%)
» More
Q1 2015

DOW Guru Trades in Q1 2015

Leon Cooperman 1,873,900 sh (New)
Jim Simons 1,884,800 sh (New)
Steven Cohen 954,625 sh (New)
Larry Robbins 6,122,700 sh (+100.28%)
Paul Tudor Jones 85,173 sh (+9.49%)
PRIMECAP Management 1,696,100 sh (+4.37%)
Pioneer Investments 1,488,635 sh (+1.44%)
First Eagle Investment 100,000 sh (unchged)
John Hussman 3,500 sh (unchged)
Steven Cohen 250,000 sh (unchged)
Daniel Loeb 22,000,000 sh (unchged)
Daniel Loeb 22,000,000 sh (unchged)
Signature Select Canadian Fund 157,500 sh (-0.76%)
Manning & Napier Advisors, Inc 202,302 sh (-3.01%)
George Soros 4,629,386 sh (-10.69%)
Dodge & Cox 693,433 sh (-11.18%)
Ray Dalio 16,895 sh (-45.83%)
Jeff Auxier 50,652 sh (-48.69%)
Joel Greenblatt 14,188 sh (-93.59%)
» More
Q2 2015

DOW Guru Trades in Q2 2015

Manning & Napier Advisors, Inc 247,035 sh (+22.11%)
» More
» Details

Insider Trades

Latest Guru Trades with DOW

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Dow Chemical Co

Daniel Loeb Comments on Dow Chemical Company - Jan 22, 2014

Third Point's largest current investment is in The Dow Chemical Company (NYSE:DOW)("Dow"). Dow shares have woefully underperformed over the last decade, generating a return of 46% (including dividends) compared to a 199% return for the S&P 500 Chemicals Index and a 101% return for the S&P 500.1 Indeed, in April 1999, nearly 15 years ago, an investor could have purchased Dow shares for the same price that they trade at today! These results reflect a poor operational track record across multiple business segments, a history of under-delivering relative to management's guidance and expectations, and the ill-timed acquisition of Rohm & Haas. The company's weak performance is even more surprising given that the North American shale gas revolution has been a powerful tailwind for Dow's largest business exposure – petrochemicals. 

We believe that Dow would be st serve shareholders' interests by engaging outside advisors to conduct a formal assessment of whether the current petrochemical operational strategy maximizes profits and if these businesses align with Dow's goal of transforming into a "specialty" chemic als company. The review should explicitly explore whether separating Dow's petrochemical businesses via a spin - off would drive greater stakeholder value.

From Daniel Loeb (Trades, Portfolio)'s Third Point fourth quarter 2013 commentary.

Dow's petrochemical operational strategy has been to migrate downstream , supposedly to earn higher m argins, to become more "specialty," and to increase the number of customer - facing products. Over the past five years, the shale revolution in North America has led to a boom in natural gas liquids production which has dramatically reduced raw material cos ts, while China and other emerging market economies have aggressively grown downstream derivatives capacity. This combination has led to significant upstream margin expansion in North America, where Dow is the largest ethylene producer, and a commoditizat ion of numerous downstream derivatives margins. Dow's current petrochemical strategy seems misaligned with the changed landscape.

Perhaps unsurprisingly, our analysis suggests that Dow's downstream migration strategy within petrochemicals has not yielded material benefits so far and instead may be a significant drag on profitability. We have examined Dow's aggregate petrochemical cap acities (and associated industry product margins) and compared its petrochemical cost base and profitability with pure - play peers. Our work suggests that upside from both cost - cutting and operating optimization could amount to several billion dollars in a nnual EBITDA. We suspect that Dow's push downstream has led the company to use its upstream assets to subsidize certain downstream derivatives either by sac rificing operational efficiency or making poor capital allocation decisions, or both. Poor segment disclosure combined with Dow's opaque and inconsistent transfer pricing methodology for internally sourced raw materials makes it difficult for shareholders (and presumably, the Board of Directors) to ascertain which business units are most challenged. W hat is easily ascertainable is that the magnitude of the aggregate under - earning warrants a c omprehensive strategic review , preferably with the assistance of an objective outside advisor answerable to a special committee of the Board.

We believe Dow shoul d apply the intelligent logic of its recently announced chlor - alkali separation to the entirety of its petrochemical businesses by creating a standalone company housing Dow's commodity petrochemical segments ("Dow Petchem Co . ") . 2 Such a separation would accomplish two important objectives. First, the split would accelerate 

Dow's transition to a true "specialty chemicals" company focused on attractive end - markets such as agriculture, food, pharmaceuticals, and electronics. Second, the standalone Dow Petchem Co . could realign its strategy away from largely focusing on downstream migration/integration and towards overall profit maximization.

The optimization of Dow Petchem Co . combined with the significant step - up in earnings from o rganic growth initiatives already put in place by management – the PDH plant, the Sadara JV, and the U.S. Gulf Co ast greenfield ethylene cracker – could translate into future EBITDA well in excess of $9 billion on a stand - alone basis . This would be before any improvement attributable to what management ref ers to as the "ethylene upcycle " . Both the " self - help " and cyclical upside opportunities create a compelling investment case, which is not reflected in Dow's current share price considering the entire co m pany's 2013 EBITDA base is ~$8 billion .

Despite Dow's best efforts to migrate downstream and become a specialty chemicals company, the market remains unconvinced. By creating Dow Petchem Co . , the strategic direction of these businesses would no longer b e dictated by the broader Dow strategy of becoming more specialty - focused. Instead, management could transform these businesses into a best - in - class, low - cost commodity petrochemical company.

The remaining Dow Chemical ("Dow Specialty Co . " ) 3 would be t he specialty chemicals leader that Dow has aspired to become over much of the past decade. Here too , we see meaningful upside over the coming years:

• In Dow's Agricultural Sciences segment, significant investments have been made in R&D which ha ve yet to t ranslate to profits, most notably in the development of Dow's ENLIST trait package. We are optimistic that ENLIST will be successfully adopted in the South American soybean market, where it has a natural first - mover advantage given that the 2,4 - D herbicide is approved for use in Brazil and Argentina. The South American soybean opportunity alone for ENLIST could i ncrease divisional EBITDA by 30 - 40% once fully penetrated.

• In the Electronics & Functional Materials segment, we see niches with strong e nd - market growth and high barriers to entry, leading to above - GDP growth rates and sustainably robust returns on invested capital.

• Finally, the Dow Corning JV represents a valuable call option on solar power adoption as total system costs for solar contin ue to compress and become 

increasingly competitive with other fossil - fuel electricity alternatives in much of the world. Dow Specialty Co . should command a premium to Dow's current multiple, and potentially a premium to other specialty chemicals companies given its attractive EBITDA growth prospects. T he market is skeptical of Dow's divisional margin targets given the lack of clarity around how they were derived and the lack of progress toward achieving them. However , even if management fails to attain t heir targets, we still see the potential for Dow Specialty Co . EBITDA to ramp up to the $4 - 5 billion range over the next 3 to 5 years , co mpared to a 2013 base of ~$2.8 billion .

We believe management's main concern about a spin - off of Dow Petchem Co . will likely relate to the integrated nature of Dow's overall portfolio. Importantly, the majority of the integration in Dow's portfolio exists between upstream / downstream petrochemicals and these businesses would remain together in Dow Petchem Co. In additi on , the integration between Dow Petchem Co . and Dow Specialty Co . is limited to commoditized raw material transfers. Having some amount of commoditized raw material integration does not create differentiation in specialty products nor does it materially i ncrease margins (unless the raw material inputs are being subsidized by Dow's petrochemical segments). The s egments within Dow Specialty Co . which primarily consist of legacy Rohm & Haas businesses and Dow's Agricult ural Sciences segment have successfully operated without raw material integration in the past , or have peers that are able to achieve higher margins without any raw material integration.

W e appr eciate this consideration; it is why we have contemplated a scenario in which bot h the upstream and downstream petrochemical businesses are spun - off together into Dow Petchem Co. W e believe the benefits from a spin - off, including financial uplift from operational improvements at Dow Petchem Co . and the potential valuation uplift from increased business focus and disclosure, far outweigh the supposed integration benefits.

Finally, as Dow management looks to further its journey in unlocking value for shareholders, it now ha s the balance sheet flexibility to consider a meaningful share buyback that could more than offset the share issuance from the conversion of the Warren Buffett (Trades, Portfolio)/KIA securities issued in conjunction with the financing of the Rohm & Haas acquisition. 4 Combined with th e Dow Petchem Co . spin - off, Dow c ould pave a path to ward increased disclosure, greater management accountability for individual business segment performances, and enhanced alignment of interests between management and shareholders. With the difficult task of balance sheet de - levering behind it, Dow finally has the opportunity to embark on its next transformational deal during CEO Andrew Liveris' tenure.

Check out Daniel Loeb latest stock trades

Top Ranked Articles about Dow Chemical Co

The Gurus to Follow Based on Sector – Part 1
GuruFocus provides information on 147 investment managers, hedge funds and mutual funds that can help guide your own investment choices. With that many portfolios, it can be difficult to narrow down which gurus to follow. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 13.60
DOW's P/E(ttm) is ranked higher than
68% of the 758 Companies
in the Global Chemicals industry.

( Industry Median: 19.30 vs. DOW: 13.60 )
Ranked among companies with meaningful P/E(ttm) only.
DOW' s 10-Year P/E(ttm) Range
Min: 6.31  Med: 15.03 Max: 116.67
Current: 13.6
6.31
116.67
Forward P/E 12.44
DOW's Forward P/E is ranked higher than
60% of the 344 Companies
in the Global Chemicals industry.

( Industry Median: 13.97 vs. DOW: 12.44 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 14.00
DOW's PE(NRI) is ranked higher than
68% of the 760 Companies
in the Global Chemicals industry.

( Industry Median: 19.50 vs. DOW: 14.00 )
Ranked among companies with meaningful PE(NRI) only.
DOW' s 10-Year PE(NRI) Range
Min: 6.34  Med: 15.21 Max: 183.24
Current: 14
6.34
183.24
P/B 2.80
DOW's P/B is ranked lower than
68% of the 952 Companies
in the Global Chemicals industry.

( Industry Median: 1.67 vs. DOW: 2.80 )
Ranked among companies with meaningful P/B only.
DOW' s 10-Year P/B Range
Min: 0.49  Med: 2.24 Max: 4.52
Current: 2.8
0.49
4.52
P/S 1.06
DOW's P/S is ranked higher than
52% of the 978 Companies
in the Global Chemicals industry.

( Industry Median: 1.06 vs. DOW: 1.06 )
Ranked among companies with meaningful P/S only.
DOW' s 10-Year P/S Range
Min: 0.12  Med: 0.76 Max: 1.33
Current: 1.06
0.12
1.33
PFCF 17.63
DOW's PFCF is ranked higher than
63% of the 491 Companies
in the Global Chemicals industry.

( Industry Median: 24.57 vs. DOW: 17.63 )
Ranked among companies with meaningful PFCF only.
DOW' s 10-Year PFCF Range
Min: 2.82  Med: 19.22 Max: 43.38
Current: 17.63
2.82
43.38
POCF 7.89
DOW's POCF is ranked higher than
75% of the 673 Companies
in the Global Chemicals industry.

( Industry Median: 13.85 vs. DOW: 7.89 )
Ranked among companies with meaningful POCF only.
DOW' s 10-Year POCF Range
Min: 1.42  Med: 9.16 Max: 20.16
Current: 7.89
1.42
20.16
EV-to-EBIT 10.33
DOW's EV-to-EBIT is ranked higher than
70% of the 776 Companies
in the Global Chemicals industry.

( Industry Median: 15.51 vs. DOW: 10.33 )
Ranked among companies with meaningful EV-to-EBIT only.
DOW' s 10-Year EV-to-EBIT Range
Min: -390.4  Med: 15.10 Max: 123.4
Current: 10.33
-390.4
123.4
PEG 1.61
DOW's PEG is ranked higher than
67% of the 349 Companies
in the Global Chemicals industry.

( Industry Median: 2.73 vs. DOW: 1.61 )
Ranked among companies with meaningful PEG only.
DOW' s 10-Year PEG Range
Min: 0.2  Med: 1.07 Max: 46.95
Current: 1.61
0.2
46.95
Shiller P/E 19.95
DOW's Shiller P/E is ranked higher than
50% of the 469 Companies
in the Global Chemicals industry.

( Industry Median: 21.89 vs. DOW: 19.95 )
Ranked among companies with meaningful Shiller P/E only.
DOW' s 10-Year Shiller P/E Range
Min: 2.36  Med: 17.89 Max: 41.67
Current: 19.95
2.36
41.67
Current Ratio 1.94
DOW's Current Ratio is ranked higher than
58% of the 869 Companies
in the Global Chemicals industry.

( Industry Median: 1.74 vs. DOW: 1.94 )
Ranked among companies with meaningful Current Ratio only.
DOW' s 10-Year Current Ratio Range
Min: 1.11  Med: 1.55 Max: 2.13
Current: 1.94
1.11
2.13
Quick Ratio 1.31
DOW's Quick Ratio is ranked higher than
55% of the 869 Companies
in the Global Chemicals industry.

( Industry Median: 1.19 vs. DOW: 1.31 )
Ranked among companies with meaningful Quick Ratio only.
DOW' s 10-Year Quick Ratio Range
Min: 0.7  Med: 1.02 Max: 1.56
Current: 1.31
0.7
1.56
Days Inventory 71.52
DOW's Days Inventory is ranked lower than
54% of the 963 Companies
in the Global Chemicals industry.

( Industry Median: 65.59 vs. DOW: 71.52 )
Ranked among companies with meaningful Days Inventory only.
DOW' s 10-Year Days Inventory Range
Min: 45.42  Med: 61.30 Max: 79.2
Current: 71.52
45.42
79.2
Days Sales Outstanding 33.46
DOW's Days Sales Outstanding is ranked higher than
81% of the 826 Companies
in the Global Chemicals industry.

( Industry Median: 58.66 vs. DOW: 33.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
DOW' s 10-Year Days Sales Outstanding Range
Min: 24.07  Med: 40.87 Max: 90.4
Current: 33.46
24.07
90.4

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.44
DOW's Dividend Yield is ranked higher than
82% of the 1112 Companies
in the Global Chemicals industry.

( Industry Median: 1.82 vs. DOW: 3.44 )
Ranked among companies with meaningful Dividend Yield only.
DOW' s 10-Year Dividend Yield Range
Min: 1.46  Med: 3.24 Max: 23.46
Current: 3.44
1.46
23.46
Dividend Payout 0.49
DOW's Dividend Payout is ranked higher than
73% of the 696 Companies
in the Global Chemicals industry.

( Industry Median: 0.34 vs. DOW: 0.49 )
Ranked among companies with meaningful Dividend Payout only.
DOW' s 10-Year Dividend Payout Range
Min: 0.17  Med: 0.47 Max: 5.58
Current: 0.49
0.17
5.58
Dividend growth (3y) 19.30
DOW's Dividend growth (3y) is ranked higher than
83% of the 417 Companies
in the Global Chemicals industry.

( Industry Median: 5.30 vs. DOW: 19.30 )
Ranked among companies with meaningful Dividend growth (3y) only.
DOW' s 10-Year Dividend growth (3y) Range
Min: -28.4  Med: 4.90 Max: 28.7
Current: 19.3
-28.4
28.7
Yield on cost (5-Year) 9.68
DOW's Yield on cost (5-Year) is ranked higher than
96% of the 1102 Companies
in the Global Chemicals industry.

( Industry Median: 2.23 vs. DOW: 9.68 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
DOW' s 10-Year Yield on cost (5-Year) Range
Min: 4.11  Med: 9.12 Max: 66.05
Current: 9.68
4.11
66.05
Share Buyback Rate -0.80
DOW's Share Buyback Rate is ranked higher than
52% of the 561 Companies
in the Global Chemicals industry.

( Industry Median: -1.00 vs. DOW: -0.80 )
Ranked among companies with meaningful Share Buyback Rate only.
DOW' s 10-Year Share Buyback Rate Range
Min: 5.5  Med: -2.40 Max: -10.6
Current: -0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 16.76
DOW's Price/Tangible Book is ranked lower than
98% of the 910 Companies
in the Global Chemicals industry.

( Industry Median: 1.75 vs. DOW: 16.76 )
Ranked among companies with meaningful Price/Tangible Book only.
DOW' s 10-Year Price/Tangible Book Range
Min: 0.88  Med: 4.01 Max: 119.83
Current: 16.76
0.88
119.83
Earnings Yield (Greenblatt) (%) 9.70
DOW's Earnings Yield (Greenblatt) (%) is ranked higher than
77% of the 988 Companies
in the Global Chemicals industry.

( Industry Median: 4.40 vs. DOW: 9.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DOW' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.8  Med: 6.50 Max: 11.8
Current: 9.7
0.8
11.8
Forward Rate of Return (Yacktman) (%) 10.36
DOW's Forward Rate of Return (Yacktman) (%) is ranked higher than
71% of the 475 Companies
in the Global Chemicals industry.

( Industry Median: 2.43 vs. DOW: 10.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
DOW' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -16.2  Med: 11.20 Max: 45.7
Current: 10.36
-16.2
45.7

Business Description

Industry: Chemicals » Chemicals
Compare:BASFY, DD, SHECY, URALL, APD » details
Traded in other countries:DOW.UK, DOWB.Belgium, DOWCP.France, DOWB34.Brazil, DOW.Switzerland, DCH1.Germany, 0Q1A.UK, DOW.Mexico, 4850.Japan,
Dow Chemical Co was incorporated in 1947 under Delaware law and is the successor to a Michigan corporation, of the same name, organized in 1897. The Company is as an integrated science and technology company. It operates in five segments: Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals and Performance Plastics. The Agricultural Sciences segment is a leader in providing crop protection and seed/plant biotechnology products and technologies, urban pest management solutions and healthy oils. The business invents, develops, manufactures and markets products for use in agricultural, industrial and commercial pest management, and food service. The Consumer Solutions segment consists of three businesses: Consumer Care, Dow Automotive Systems and Dow Electronic Materials. These businesses develop and market customized materials using technology and chemistries for specialty applications - including semiconductors and organic light-emitting diodes, adhesives and foams used by the transportation industry, and cellulosics for pharmaceutical formulations and food solutions. The Consumer Care portfolio of businesses delivers technologies for the consumer at the intersection of physics, biology and chemistry, connecting the businesses to the human element. Dow Electronic Materials is a supplier of enabling materials for a broad range of consumer electronics including smartphones, tablets, television monitors and personal computers, as well as electronic devices and systems used in a variety of industries. Dow Automotive Systems is a provider of collaborative solutions and materials for original equipment manufacturers, tier suppliers, aftermarket customers and commercial transportation manufacturers. The Infrastructure Solutions segment is comprised of an portfolio of businesses utilizing technology to deliver products such as architectural and industrial coating applications, building insulation, adhesives, microbial protection for the oil and gas industry, and water technologies. The Performance Materials & Chemicals segment is comprised of five technology-driven, customer-centric businesses that are advantaged through integration and driven by technology and solutions: Chlor-Alkali and Vinyl, Chlorinated Organics, Epoxy, Industrial Solutions and Polyurethanes. The Performance Plastics segment is the world's plastics franchise, and is a market-oriented portfolio composed of five businesses: Dow Elastomers, Dow Electrical and Telecommunications, Dow Packaging and Specialty Plastics, Energy and Hydrocarbons.
» More Articles for DOW

Headlines

Articles On GuruFocus.com
Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
Schulman Posts Weaker-Than-Expected Q2 Results Apr 08 2015 
Dow Divest Chlorine Business For $5 Billion Mar 30 2015 
Diamond Hill Capital Large Cap Commentary: Capital One, Eastman Chemical Mar 18 2015 
Dogs Of The S&P 500 - No Dividend Alternatives Are Cheaper! Feb 21 2015 
Ruane Cunniff Has Most Active Quarter of the Year – So Far Dec 10 2014 
Big News Last Week Nov 19 2014 
Activist Investor Dan Loeb's Video Challenging Dow Chemical Nov 14 2014 
Hedge Fund Passport Capital Buys Yahoo!, Dollar General Corp, Liberty Global, Sells Qihoo 360, Vipsh Nov 14 2014 
The Gurus to Follow Based on Sector – Part 1 Nov 03 2014 

More From Other Websites
Key Sector Threatening Material Breakdown Jul 31 2015
The Dow Chemical Co. Earnings Analysis: By the Numbers Jul 30 2015
5:47 pm Dow Chemical Chairman and CEO Andrew Liveris issues statement on Congress' failure to... Jul 29 2015
Statement from Andrew N. Liveris, Chairman and CEO, The Dow Chemical Company on Congress’ Failure... Jul 29 2015
Boulevard Acquisition Corp. Stockholders Approve Acquisition Of AgroFresh Business From The Dow... Jul 29 2015
Twenty-One Dow Technologies Selected as Finalists for 2015 R&D 100 Awards Jul 29 2015
DOW CHEMICAL CO /DE/ Files SEC form 10-Q, Quarterly Report Jul 29 2015
Dow Corning Reports Increased Profits for First Half of 2015 Jul 29 2015
DuPont's Earnings Don't Show Need To Rethink CEO Ellen Kullman's Turnaround Plan Jul 28 2015
Zacks Investment Ideas feature highlights: Precision Drilling, Aaron's and Dow Chemical - Press... Jul 28 2015
Cramer to See if Dupont's Guidance Is the Right Chemistry for Investors Jul 24 2015
Clinton lashes out at activists in Apple, others Jul 24 2015
Company News for July 24, 2015 - Corporate Summary Jul 24 2015
Caterpillar, 3M, Dow Sales Hit By Weak Global Growth Jul 23 2015
Corporate Winners and Losers from Oil-Price Decline Jul 23 2015
Dow Chemical (DOW) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
Edited Transcript of DOW earnings conference call or presentation 23-Jul-15 1:00pm GMT Jul 23 2015
2 Wall Street CEOs Speak Out As Greece Ups Austerity Jul 23 2015
4 Stocks, 4 trades: DOW, LVS, BAC & GM Jul 23 2015
Dow Chemical Q2 Earnings Outshine, Currency Dents Sales - Analyst Blog Jul 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK